Fujisawa, Japan

Ryoichi Miyata

This inventor holds 2 USPTO granted patents. Top assignees: Mercian Corporation, Sanraku Incorporated. Active years: 1991-1992.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryoichi Miyata: Innovator in Pharmaceutical Chemistry

Introduction

Ryoichi Miyata is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 2 patents, his work has had a meaningful impact on drug development.

Latest Patents

Miyata's latest patents include a process for producing azetidinone derivatives. This process focuses on creating 2-azetidinone derivatives represented by a specific formula, wherein R.sup.1 denotes a protecting group of a hydroxyl group. Another significant patent involves anthracycline derivatives, specifically 14-trifluoromethanesulfonyloxydaunomycin, which serves as an important intermediate for the production of adriamycin.

Career Highlights

Throughout his career, Ryoichi Miyata has worked with prominent companies such as Mercian Corporation and Sanraku Incorporated. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Miyata has collaborated with esteemed colleagues, including Takeo Yoshioka and Toshio Tsuchida. These partnerships have contributed to his success and the advancement of his research.

Conclusion

Ryoichi Miyata's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…